Learn more

GLYCOZYM APS

Overview
  • Total Patents
    32
About

GLYCOZYM APS has a total of 32 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SINOVET BEIJING BIOTECHNOLOGY CO LTD, FUNDACIO INST D INVESTIGACIO BIOMEDICA DE BELLVITGE IDIBELL and REED JOHN C.

Patent filings per year

Chart showing GLYCOZYM APSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Clausen Henrik 30
#2 Schwientek Tilo 16
#3 Bennett Eric Paul 13
#4 Steffensen Rudi 4
#5 Hassan Helle 3
#6 Reis Celso Albuquerque 2
#7 Amado Margarida 2
#8 Bennett Eric P 1
#9 Henrik Clausen 1

Latest patents

Publication Filing date Title
US2006099699A1 UDP-galactose:β-N-acetyl-glucosamine β-1,3-galactosyl transferases, β-3Gal-T5
US2004142425A1 UDP-galactose: β-N-acetyl-glucosamine β1,3 galactosyltransferases, β3gal-T5
WO2004042075A2 Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use
AU2003248317A1 UDP-N-acetylglucosamine: galactose-B1, 3-N-acetylgalactosamine-a-R/N-acetylglucosamine-B1, 3-N-acetylgalactosamine-a-R (GlcNAc to GalNAc) B1, 6-N-acetylglucosaminyltransferase, C2/4GnT
US2003186850A1 Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
US2003013173A1 UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2
EP1282725A2 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR
AU3152801A UDP-galactose: beta-D-galactose-R 4-alpha-D-galactosyltransferase, alpha4Gal-T1
NZ517219A Nucleic acids and polypeptides used to modulate the biological activity of a C2GnT3 polypeptide and treat proliferative diseases such as cancer and thymus-related disorders
AU1503700A UDP-N- acetyl glucosamine: galactose-beta1, 3-N- acetyl galactosamine- alpha-R/ N- acetyl glucosamine -beta1, 3-N- acetyl galactosamine- alpha-R (GlcNAc to GalNAc) beta1,6-N- acetyl glucosaminyl transferase, C2/4GnT
US6465220B1 Glycosylation using GalNac-T4 transferase